Matches in Nanopublications for { ?s ?p "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP270822.RACymB7YXJZaid8dNZKuuRzl94-Ea_n2T6zomz1XIETH0130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270822.RACymB7YXJZaid8dNZKuuRzl94-Ea_n2T6zomz1XIETH0130_provenance.
- NP800851.RAaoAEw_d4Wvinfxwztmw105prrYchiogLJDMjqQgCtKc130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800851.RAaoAEw_d4Wvinfxwztmw105prrYchiogLJDMjqQgCtKc130_provenance.
- NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166299.RAdj5_dflLX0cBV4jjVrOQHpha6yMdN0GUCf9mpTO1KhQ130_provenance.
- NP405429.RA3MOIVYcCDBLDfr8FJAQU0V86ANcx7I4qy9zY4Lu6aFg130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405429.RA3MOIVYcCDBLDfr8FJAQU0V86ANcx7I4qy9zY4Lu6aFg130_provenance.
- NP164694.RA0jAnAF8FOnZjRnpeE3AORXu2SUDY6ozObBLSksU3WBY130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164694.RA0jAnAF8FOnZjRnpeE3AORXu2SUDY6ozObBLSksU3WBY130_provenance.
- NP801273.RAuQktDOYoM_4KE0tQ-_QQvint-3v0c4YQ9tKGkm-oDTo130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801273.RAuQktDOYoM_4KE0tQ-_QQvint-3v0c4YQ9tKGkm-oDTo130_provenance.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.
- assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP710073.RAS5jXxvnD8hN2RPsziK0_9T5Ug9jPS0PO2C8g8CuFUfE130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710073.RAS5jXxvnD8hN2RPsziK0_9T5Ug9jPS0PO2C8g8CuFUfE130_provenance.